Neonatal and Pediatric Antimicrobial Stewardship Programs in Europe—Defining the Research Agenda

Pediatric Infectious Disease Journal

Volumn 32, Issue 12, 2013, Pages e456-e465

  Brett, Ana ^a   Bielicki, Julia ^a   Newland, Jason G ^a   Rodrigues, Fernanda ^a   Schaad, Urs B ^a   Sharland, Mike ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Antibacterial agents; Drug utilization; Hospitals; Pediatric standards; Program evaluation

Indexed keywords

ANTIINFECTIVE AGENT;

DRUG USE; DRUG UTILIZATION; EUROPE; HOSPITAL; HUMAN; PEDIATRICS; STANDARDS; STATISTICS AND NUMERICAL DATA; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL STEWARDSHIP PROGRAM; HEALTH CARE SYSTEM; MEDICAL SOCIETY; MEDICATION THERAPY MANAGEMENT; PRIORITY JOURNAL; PROGRAM COST EFFECTIVENESS; REVIEW; STUDY DESIGN;

ANTI-INFECTIVE AGENTS; DRUG UTILIZATION; DRUG UTILIZATION REVIEW; EUROPE; HOSPITALS, PEDIATRIC; HUMANS; PEDIATRICS;

EID: 84891739017     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31829f0460     Document Type: Review

References (94)

1. van Houten MA, Luinge K, Laseur M, et al. Antibiotic utilisation for hospitalised paediatric patients. Int J Antimicrob Agents. 1998;10:161-164
2. Clavenna A, Bonati M. Drug prescriptions to outpatient children: a review of the literature. Eur J Clin Pharmacol. 2009;65:749-755
3. Potocki M, Goette J, Szucs TD, et al. Prospective survey of antibiotic utilization in pediatric hospitalized patients to identify targets for improvement of prescription. Infection. 2003;31:398-403
4. Goossens H, Ferech M, Vander Stichele R, et al.ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-587
5. MacDougall C, Powell JP, Johnson CK, et al. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005;41:435-440
6. de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother. 2011;66:398-407
7. Cassir N, Di Marco JN, Poujol A, et al. Underestimated impact of antibiotic misuse in outpatient children. Arch Pediatr. 2012;19:579-584
8. Cohen AL, Budnitz DS, Weidenbach KN, et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J Pediatr. 2008;152:416-421
9. Ghaleb MA, Barber N, Franklin BD, et al. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child. 2010;95:113-118
10. Zaoutis TE, Prasad PA, Localio AR, et al. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38-e45
11. Sandora TJ, Fung M, Flaherty K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J. 2011;30:580-584
12. Honkinen M, Lahti E, Österback R, et al. Viruses and bacteria in sputum samples of children with community-acquired pneumonia. Clin Microbiol Infect. 2012;18:300-307
13. Hersh AL, Shapiro DJ, Pavia AT, et al. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011;128:1053-1061
14. Henderson M, Rubin E. Misuse of antimicrobials in children with asthma and bronchiolitis: a review. Pediatr Infect Dis J. 2001;20:214-215
15. Samson L, Cooke C, Macdonald N. Analysis of antibiotic use and misuse in children hospitalized with RSV infection. Paediatr Child Health. 1999;4:195-199
16. Pulcini C, Bush K, Craig WA, et al.ESCMID Study Group for Antibiotic Policies. Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia. Clin Infect Dis. 2012;54:268-274
17. Bruce J, MacKenzie FM, Cookson B, et al.ARPAC Steering Group. Antibiotic stewardship and consumption: findings from a pan-European hospital study. J Antimicrob Chemother. 2009;64:853-860
18. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA. 1996;275:234-240
19. Davey P, Brown E, Fenelon L, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2005;4:CD003543
20. Dellit TH, Owens RC, McGowan JE Jr, et al.Infectious Diseases Society of America; Society for Healthcare Epidemiology of America. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-177
21. Wesche D, Deen PM, Knoers NV. Congenital nephrogenic diabetes insipidus: the current state of affairs. Pediatr Nephrol. 2012;27:2183-2204
22. Newland JG, Hersh AL. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010;29:862-863
23. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis. 2010;10:167-175
24. Edwards R, Charani E, Sevdalis N, et al. Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis. 2012;12:318-329
25. Toltzis P, Yamashita T, Vilt L, et al. Antibiotic restriction does not alter endemic colonization with resistant gram-negative rods in a pediatric intensive care unit. Crit Care Med. 1998;26:1893-1899
26. Noyola DE, Demmler GJ. Effect of rapid diagnosis on management of influenza A infections. Pediatr Infect Dis J. 2000;19:303-307
27. Sáez-Llorens X, Castrejón de Wong MM, Castaño E, et al. Impact of an antibiotic restriction policy on hospital expenditures and bacterial susceptibilities: a lesson from a pediatric institution in a developing country. Pediatr Infect Dis J. 2000;19:200-206
28. Mullett CJ, Evans RS, Christenson JC, et al. Development and impact of a computerized pediatric antiinfective decision support program. Pediatrics. 2001;108:E75
29. Byington CL, Castillo H, Gerber K, et al. The effect of rapid respiratory viral diagnostic testing on antibiotic use in a children’s hospital. Arch Pediatr Adolesc Med. 2002;156:1230-1234
30. Moss WJ, Beers MC, Johnson E, et al. Pilot study of antibiotic cycling in a pediatric intensive care unit. Crit Care Med. 2002;30:1877-1882
31. Wilson SD, Dahl BB, Wells RD. An evidence-based clinical pathway for bronchiolitis safely reduces antibiotic overuse. Am J Med Qual. 2002;17:195-199
32. South M, Royle J, Starr M. A simple intervention to improve hospital antibiotic prescribing. Med J Aust. 2003;178:207-209
33. Bolon MK, Arnold AD, Feldman HA, et al. An antibiotic order form intervention does not improve or reduce vancomycin use. Pediatr Infect Dis J. 2005;24:1053-1058
34. Lee J, Pai H, Kim YK, et al. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children’s hospital by changing antimicrobial agent usage policy. J Antimicrob Chemother. 2007;60:629-637
35. Metjian TA, Prasad PA, Kogon A, et al. Evaluation of an antimicrobial stewardship program at a pediatric teaching hospital. Pediatr Infect Dis J. 2008;27:106-111
36. Agwu AL, Lee CK, Jain SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis. 2008;47:747-753
37. Berild D, Abrahamsen TG, Andresen S, et al. A controlled intervention study to improve antibiotic use in a Russian paediatric hospital. Int J Antimicrob Agents. 2008;31:478-483
38. Ding H, Yang Y, Wei J, et al. Influencing the use of antibiotics in a Chinese pediatric intensive care unit. Pharm World Sci. 2008;30:787-793
39. Akter SF, Heller RD, Smith AJ, et al. Impact of a training intervention on use of antimicrobials in teaching hospitals. J Infect Dev Ctries. 2009;3:447-451
40. Di Pentima MC, Chan S, Eppes SC, et al. Antimicrobial prescription errors in hospitalized children: role of antimicrobial stewardship program in detection and intervention. Clin Pediatr (Phila). 2009;48:505-512
41. Dommett R, Geary J, Freeman S, et al. Successful introduction and audit of a step-down oral antibiotic strategy for low risk paediatric febrile neutropaenia in a UK, multicentre, shared care setting. Eur J Cancer. 2009;45:2843-2849
42. Doyon S, Perreault M, Marquis C, et al. Quantitative evaluation of a clinical intervention aimed at changing prescriber behaviour in response to new guidelines. J Eval Clin Pract. 2009;15:1111-1117
43. Di Pentima MC, Chan S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J. 2010;29:707-711
44. Di Pentima MC, Chan S, Hossain J. Benefits of a pediatric antimicrobial stewardship program at a children’s hospital. Pediatrics. 2011;128:1062-1070
45. Esposito S, Tagliabue C, Picciolli I, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respir Med. 2011;105:1939-1945
46. Levy ER, Swami S, Dubois SG, et al. Rates and appropriateness of antimicrobial prescribing at an academic children’s hospital, 2007-2010. Infect Control Hosp Epidemiol. 2012;33:346-353
47. Newland JG, Stach LM, DeLurgio SA, et al. Impact of a prospective-audit-with-feedback antimicrobial stewardship program at a children’s hospital. J Pediatr Infect Dis Soc. 2012;1:179-186
48. Newman RE, Hedican EB, Herigon JC, et al. Impact of a guideline on management of children hospitalized with community-acquired pneumonia. Pediatrics. 2012;129:e597-e604
49. Smith MJ, Kong M, Cambon A, et al. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children. Pediatrics. 2012;129:e1326-e1333
50. Ehl S, Gering B, Bartmann P, et al. C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics. 1997;99:216-221
51. Calil R, Marba ST, von Nowakonski A, et al. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control. 2001;29:133-138
52. Franz AR, Steinbach G, Kron M, et al. Interleukin-8: a valuable tool to restrict antibiotic therapy in newborn infants. Acta Paediatr. 2001;90:1025-1032
53. Toltzis P, Dul MJ, Hoyen C, et al. The effect of antibiotic rotation on colonization with antibiotic-resistant bacilli in a neonatal intensive care unit. Pediatrics. 2002;110:707-711
54. Franz AR, Bauer K, Schalk A, et al.International IL-8 Study Group. Measurement of interleukin 8 in combination with C-reactive protein reduced unnecessary antibiotic therapy in newborn infants: a multicenter, randomized, controlled trial. Pediatrics. 2004;114:1-8
55. Couto RC, Barbosa JA, Pedrosa TM, et al. C-reactive protein-guided approach may shorten length of antimicrobial treatment of culture-proven late-onset sepsis: an intervention study. Braz J Infect Dis. 2007;11:240-245
56. de Araujo OR, da Silva DC, Diegues AR, et al. Cefepime restriction improves gram-negative overall resistance patterns in neonatal intensive care unit. Braz J Infect Dis. 2007;11:277-280
57. Labenne M, Michaut F, Gouyon B, et al. A population-based observational study of restrictive guidelines for antibiotic therapy in early-onset neonatal infections. Pediatr Infect Dis J. 2007;26:593-599
58. Murki S, Jonnala S, Mohammed F, et al. Restriction of cephalosporins and control of extended spectrum beta-lactamase producing gram negative bacteria in a neonatal intensive care unit. Indian Pediatr. 2010;47:785-788
59. Stocker M, Fontana M, El Helou S, et al. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis: prospective randomized intervention trial. Neonatology. 2010;97:165-174
60. Liem TY, Van Den Hoogen A, Rademaker CM, et al. Antibiotic weight-watching: slimming down on antibiotic use in a NICU. Acta Paediatr. 2010;99:1900-1902
61. Chiu CH, Michelow IC, Cronin J, et al. Effectiveness of a guideline to reduce vancomycin use in the neonatal intensive care unit. Pediatr Infect Dis J. 2011;30:273-278
62. Zingg W, Pfister R, Posfay-Barbe KM, et al. Secular trends in antibiotic use among neonates: 2001-2008. Pediatr Infect Dis J. 2011;30:365-370
63. van Esso D, del Torso S, Hadjipanayis A, et al.Primary-Secondary Working Group (PSWG) of European Academy of Paediatrics (EAP). Paediatric primary care in Europe: variation between countries. Arch Dis Child. 2010;95:791-795
64. Patel SJ, Larson EL, Kubin CJ, et al. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26:531-537
65. Ramsay C, Brown E, Hartman G, et al. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother. 2003;52:764-771
66. Hersh AL, Beekmann SE, Polgreen PM, et al. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol. 2009;30:1211-1217
67. Patel SJ, Larson EL, Kubin CJ, et al. A review of antimicrobial control strategies in hospitalized and ambulatory pediatric populations. Pediatr Infect Dis J. 2007;26:531-537
68. Du W, Warrier I, Tutag Lehr V, et al. Changing patterns of drug utilization in a neonatal intensive care population. Am J Perinatol. 2006;23:279-285
69. Warrier I, Du W, Natarajan G, et al. Patterns of drug utilization in a neonatal intensive care unit. J Clin Pharmacol. 2006;46:449-455
70. Liem TB, Krediet TG, Fleer A, et al. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother. 2010;65:1270-1275
71. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance. Pediatr Infect Dis J. 2009;28:1047-1051
72. Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2006;42(suppl 2):S82-S89
73. Shlaes DM, Gerding DN, John JF Jr, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-599
74. Patel SJ, Rosen E, Zaoutis T, et al. Neonatologists’ perceptions of antimicrobial resistance and stewardship in neonatal intensive care units. Infect Control Hosp Epidemiol. 2010;31:1298-1300
75. Center for Disease Control and Prevention. Transatlantic Taskforce on Antimicrobial Resistance - Recommendations for future collaboration between the U.S. and EU. 2011. Available at: http://www.cdc.gov/drugresistance/pdf/tatfar-report.pdf. Accessed November 21, 2011
76. EARS-Net. Antimicrobial resistance surveillance in Europe 2010. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011. Available at: http://ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=774. Accessed June 10, 2012
77. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66(suppl 6):vi71-77
78. Henderson KL, Muller-Pebody B, Johnson AP, et al.ARPEC Group. First set-up meeting for Antibiotic Resistance and Prescribing in European Children (ARPEC). Euro Surveill. 2009;14:19404
79. Mintegi S, Shavit I, Benito JREPEM group (Research in European Paediatric Emergency Medicine). Pediatric emergency care in europe: a descriptive survey of 53 tertiary medical centers. Pediatr Emerg Care. 2008;24:359-363
80. Nipshagen MD, Polderman KH, DeVictor D, et al. Pediatric intensive care: result of a European survey. Intensive Care Med. 2002;28:1797-1803
81. Lusini G, Lapi F, Sara B, et al. Antibiotic prescribing in paediatric populations: a comparison between Viareggio, Italy and Funen, Denmark. Eur J Public Health. 2009;19:434-438
82. de Jong J, van den Berg PB, de Vries TW, et al. Antibiotic drug use of children in the Netherlands from 1999 till 2005. Eur J Clin Pharmacol. 2008;64:913-919
83. Rossignoli A, Clavenna A, Bonati M. Antibiotic prescription and prevalence rate in the outpatient paediatric population: analysis of surveys published during 2000-2005. Eur J Clin Pharmacol. 2007;63:1099-1106
84. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ. 2009;338:b2242
85. Allerberger F, Gareis R, Jindrák V, et al. Antibiotic stewardship implementation in the EU: the way forward. Expert Rev Anti Infect Ther. 2009;7:1175-1183
86. Grossman Z, Del Torso S, Hadjipanayis A, et al. Antibiotic prescribing for upper respiratory infections: European primary paediatricians’ knowledge, attitudes and practice. Acta Paediatr. 2012;101:935-940
87. Suresh GK, Edwards WH. Central line-associated bloodstream infections in neonatal intensive care: changing the mental model from inevitability to preventability. Am J Perinatol. 2012;29:57-64
88. Resar R, Griffin FA, Haraden C, et al. Using Care Bundles to Improve Health Care Quality. IHI Innovation Series white paper. 2012 Cambridge, Massachusetts Institute for Healthcare Improvement
89. Awad SS, Palacio CH, Subramanian A, et al. Implementation of a methicillin-resistant Staphylococcus aureus (MRSA) prevention bundle results in decreased MRSA surgical site infections. Am J Surg. 2009;198:607-610
90. Kim JS, Holtom P, Vigen C. Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: epidemiologic and economic consequences. Am J Infect Control. 2011;39:640-646
91. Miller MR, Niedner MF, Huskins WC, et al.National Association of Children’s Hospitals and Related Institutions Pediatric Intensive Care Unit Central Line-Associated Bloodstream Infection Quality Transformation Teams. Reducing PICU central line-associated bloodstream infections: 3-year results. Pediatrics. 2011;128:e1077-e1083
92. Cooke FJ, Holmes AH. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents. 2007;30:25-29
93. Pulcini C, Defres S, Aggarwal I, et al. Design of a ‘day 3 bundle’ to improve the reassessment of inpatient empirical antibiotic prescriptions. J Antimicrob Chemother. 2008;61:1384-1388
94. Ashiru-Oredope D, Sharland M, Charani E, et al.ARHAI Antimicrobial Stewardship Group. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother. 2012;67(suppl 1):i51-i63